23
Jun2022

In recognition of Pride Month, we'd like to highlight some resources—both from PRIM&R and from other organizations—that explore the importance of recognizing and including LGBTQIA+ people in research, strategies for reviewing LGBTQIA-specific research, and the unique ethical considerations for research with LGBTQIA+ populations (particularly children and youth). Read more

22
Jun2022

This month’s Research Ethics Roundup covers enduring "publish or perish" incentives, a new grant program to increase the number of funded Black researchers, a beagle facility's impending closure, and lagging trial representation for older cancer patients. Read more

9
Jun2022

On April 14, 2022, the FDA released draft guidance that aims to diversify the population of participants in clinical trials. Because the guidance is a draft, its content is open for public discussion and comment. Earlier this week, PRIM&R submitted comment to the FDA explaining how the guidance, while welcome, might be improved. Comments are due June 13, 2022, and we encourage others to submit their own comments (and feel free to borrow from ours)! Read more

3
Jun2022

Diversity, equity, and inclusion have become a focal point since the COVID-19 pandemic exposed the disproportionate —and systemically ingrained— health disparities certain populations suffer from in the United States. IRBs have the difficult responsibility of both protecting participants from harm and ensuring the inclusion of underrepresented participants in research. Read more